1.600
+0,00%
2026-10-16
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +42.4% | +26.7% | 2 / 3 | -26.8% | +35.69 pp | +21.50 pp | -6.6% | 0.33 | — | 1,7 | −26,8% | −1,3 | +42,4% | — | -2.37 | — |
| Pts | 8 | 4 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.600 (close price on 2026-10-16)EPS (TTM): −347,2
Financial charts
1.Revenue & growth
VND bn1,69Q2/26
1.Revenue & growth
VND bn1,69Q2/26
2.Profit & growth
VND bn-5,20Q2/26
3.Profit mix (Penman)
VND bn-10,8Q2/26
4.Margins & cost structure
%26.2%Q2/26
5.Returns & cash cycle
% · days-7.7%Q2/26
6.Earnings quality & cash
VND bn0,14Q2/26
7.Asset structure
VND bn174Q2/26
8.Funding & debt health
VND bn · times174Q2/26
9.Revenue backlog
VND bn2,89Q2/26
10.Valuation
times · %-2,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-260Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26